WORLDWIDE‑CORRUPTION

China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)

北京紫竹医药经营有限公司

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (北京市市场监管局北京市市场监管局 · 市场监管总局发布北京紫竹医药经营有限公司达成并实施垄断协议案行政处罚决定书), from 29 May 2023.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).

Details

Company
北京紫竹医药经营有限公司
Authority
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
Decision
Cartel (monopoly agreement)
Grounds and details, as published
北京市市场监管局北京市市场监管局 · 市场监管总局发布北京紫竹医药经营有限公司达成并实施垄断协议案行政处罚决定书
From
29 May 2023
Until
—
Status
End date not published
Source
https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_c1e2b2afb9774086834cff4a5d052149.html
Licence
Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)

SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)